Fortress Biotech Inc (FBIO)
1.67
-0.05
(-2.91%)
USD |
NASDAQ |
May 10, 16:00
1.67
0.00 (0.00%)
After-Hours: 20:00
Fortress Biotech Cash from Investing (TTM): -2.103M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -2.103M |
September 30, 2023 | -2.431M |
June 30, 2023 | -8.323M |
March 31, 2023 | -6.591M |
December 31, 2022 | -22.93M |
September 30, 2022 | 30.82M |
June 30, 2022 | 24.17M |
March 31, 2022 | 19.64M |
December 31, 2021 | 40.51M |
September 30, 2021 | -14.41M |
June 30, 2021 | -9.623M |
March 31, 2021 | -5.846M |
December 31, 2020 | -7.164M |
September 30, 2020 | -5.287M |
June 30, 2020 | -6.279M |
March 31, 2020 | -5.827M |
December 31, 2019 | 20.10M |
September 30, 2019 | 33.31M |
June 30, 2019 | 46.39M |
March 31, 2019 | 44.81M |
December 31, 2018 | 18.82M |
September 30, 2018 | 11.08M |
June 30, 2018 | -23.09M |
March 31, 2018 | -41.12M |
December 31, 2017 | -40.22M |
Date | Value |
---|---|
September 30, 2017 | -47.31M |
June 30, 2017 | -20.30M |
March 31, 2017 | -4.299M |
December 31, 2016 | -6.06M |
September 30, 2016 | 34.46M |
June 30, 2016 | 11.00M |
March 31, 2016 | 13.47M |
December 31, 2015 | 7.885M |
September 30, 2015 | -54.01M |
June 30, 2015 | -32.76M |
March 31, 2015 | -31.31M |
December 31, 2014 | -23.27M |
September 30, 2014 | -0.596M |
June 30, 2014 | -0.467M |
March 31, 2014 | -0.436M |
December 31, 2013 | -0.188M |
September 30, 2013 | -0.466M |
June 30, 2013 | -0.545M |
March 31, 2013 | -0.281M |
December 31, 2012 | -0.279M |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | -0.034M |
December 31, 2011 | -3.843M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-22.93M
Minimum
Dec 2022
46.39M
Maximum
Jun 2019
6.217M
Average
-5.287M
Median
Sep 2020
Cash from Investing (TTM) Benchmarks
Journey Medical Corp | -5.00M |
Avenue Therapeutics Inc | -- |
Mustang Bio Inc | 5.886M |
Checkpoint Therapeutics Inc | -- |
Viking Therapeutics Inc | -641.08M |